Substituted oxadiazoles: a patent review (2010 – 2012)

Author： Zarghi Afshin   Hajimahdi Zahra  

Publisher： Informa Healthcare

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.23, Iss.9, 2013-09, pp. : 1209-1232

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

New substituted benzimidazole derivatives: a patent review (2010 – 2012)

By Fei Fan   Zhou Zhiming  

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 9, 2013-09 ,pp. : 1157-1179

Informa Healthcare

Access to resources Recommend Favorite

Sphingosine 1-phosphate receptor agonists: a patent review (2010 - 2012)

By Roberts Edward  

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 7, 2013-07 ,pp. : 817-841

Informa Healthcare

Access to resources Recommend Favorite

mGlu5 negative allosteric modulators: a patent review (2010 – 2012)

By Emmitte Kyle A  

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 4, 2013-04 ,pp. : 393-408

Informa Healthcare

Access to resources Recommend Favorite

BACE2 as a new diabetes target: a patent review (2010 – 2012)

By Southan Christopher  

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 5, 2013-05 ,pp. : 649-663

Informa Healthcare

Access to resources Recommend Favorite

Small-molecule inhibitors/modulators of amyloid-β peptide aggregation and toxicity for the treatment of Alzheimer's disease: a patent review (2010 – 2012)

By Belluti Federica   Rampa Angela   Gobbi Silvia   Bisi Alessandra  

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 5, 2013-05 ,pp. : 581-596

Informa Healthcare

Access to resources Recommend Favorite